Amber N. Khan, MD

a:1:{i:0;s:73:"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut";}

PCC
Dextromethorphan-Quinidine for Agitation in Dementia
Narrative Review

November 14, 2024

The authors provide an updated summary of the literature on dextromethorphan-quinidine for the treatment of agitation in patients with dementia.
, ,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe